Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
79.2M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
75.5M
-
Shares change
-
-1.2M
-
Total reported value, excl. options
-
$132M
-
Value change
-
-$5.13M
-
Number of buys
-
40
-
Number of sells
-
-32
-
Price
-
$1.75
Significant Holders of Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) as of Q4 2021
98 filings reported holding SLDB - Solid Biosciences Inc. - Common Stock, $0.001 par value per share as of Q4 2021.
Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75.5M shares
of 79.2M outstanding shares and own 95.36% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (13.4M shares), RA CAPITAL MANAGEMENT, L.P. (12.4M shares), EcoR1 Capital, LLC (9.2M shares), Bain Capital Life Sciences Investors, LLC (7.93M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (6.29M shares), BlackRock Inc. (6.25M shares), BOXER CAPITAL, LLC (3.18M shares), Artal Group S.A. (3M shares), VANGUARD GROUP INC (2.58M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.02M shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.